Top Left party leader Ines Schwerdtner demonstrated against the federal cabinet’s healthcare reform plans and criticized the federal government for creating social imbalances. On Wednesday, she stated that the proposed reform would lead to increasing contributions and higher medication costs. Schwerdtner’s principal criticism is that the financial burden will disproportionately fall upon patients and working individuals, a situation she vehemently rejects.
Instead, Schwerdtner demanded a universal citizen’s insurance model where participation would be mandatory for all, arguing that wealthy citizens and pharmaceutical conglomerates must contribute more significantly. She vowed continued resistance to the plans, asserting that the political process would not sacrifice either medical staff or patients. Considering that efforts are being made to cut costs in areas of health, pensions, and basic public services, she called the current approach “absolute madness”.
Echoing this stance, Schwerdtner’s co-party boss, Jan van Aken, told the “Welt” that the plan was not a reform but an “attack on all of us”. He noted that the pharmaceutical lobby and large corporations are the primary beneficiaries. For average workers, the reform translates into more fees, longer wait times, and substandard care. The Left party chair pointed out that the fundamental problem of “unfair” health insurance financing-namely, the protection of profits for pharmaceutical companies and the continuity of a “two-tier medical system”-remains unresolved. This, he alleged, is due to a failure to confront the nation’s billionaires, instead focusing on ways to extract money from the populace.
Adding to the criticism, Markus Blumenthal-Beier, the federal chairman of the General Practitioners Association, sharply criticized the reform of the public health insurance system. He called for immediate amendments and warned of protest actions.
Blumenthal-Beier told media houses that the reform does not represent fair burden sharing, but rather “a disorganized collection of cuts”. He argued that while the pharmaceutical industry and insurance management bodies would be protected, the people who provide daily care would be the primary ones cut back. Furthermore, he warned that the current legislative draft jeopardizes the implementation of essential structural reforms, particularly the primary care system model used by general practitioners, before the reform can even begin.
He questioned the rationale behind financially sanctioning general practices when they already coordinate care for more patients through demonstrably effective existing HMO contracts. This criticism suggests that the intended implementation of the primary care system is now far off.
Blumenthal-Beier urged the Federal Minister of Health, Nina Warken (CDU), to address the flaws during the parliamentary process, stressing that this is her current opportunity to prevent the worst outcomes through targeted revisions. Otherwise, statutory insured individuals will feel the consequences acutely. He concluded with a warning that doctors are not prepared to repeatedly absorb mismanagement if they are simultaneously faced with political obstacles, promising that the medical community would resort to protests if their concerns are disregarded.